A pilot study to assess smokeless tobacco use reduction with varenicline

Nicotine and Tobacco Research

Volumn 12, Issue 10, 2010, Pages 1037-1040

  Ebbert, Jon O ^a   Croghan, Ivana T ^a   North, Frederick ^a   Schroeder, Darrell R ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARENICLINE;

ABDOMINAL PAIN; ABSTINENCE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DYSPEPSIA; FATIGUE; HEART PALPITATION; HUMAN; MALE; MOTIVATION; NAUSEA; PATIENT ATTITUDE; PILOT STUDY; PRIORITY JOURNAL; RASH; SLEEP DISORDER; SMOKELESS TOBACCO; SUICIDAL IDEATION; TOBACCO DEPENDENCE; TREATMENT DURATION; TREMOR; VIVID DREAM; WITHDRAWAL SYNDROME;

ADULT; BEHAVIOR; BENZAZEPINES; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; QUINOXALINES; SMOKING CESSATION; TOBACCO, SMOKELESS;

EID: 77957747183     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntq134     Document Type: Article

References (17)

1. Benowitz, N. L., Ahijevych, K., Hall, S., Hansson, A., Henningfield, J., Hurt, R. D., et al. (2002). Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4, 149-159.
2. Cappelleri, J. C., Bushmakin, A. G., Baker, C. L., Merikle, E., Olufade, A. O., & Gilbert, D. G. (2007). Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addictive Behaviors, 32, 912-923.
3. Ebbert, J. O., Patten, C. A., & Schroeder, D. R. (2006). The Fagerstrom Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST). Addictive Behaviors, 31, 1716-1721.
4. Faessel, H. M., Gibbs, M. A., Clark, D. J., Rohrbacher, K., Stolar, M., & Burstein, A. H. (2006). Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers. Journal of Clinical Pharmacology, 46, 1439-1448.
5. Falba, T., Jofre-Bonet, M., Busch, S., Duchovny, N., & Sindelar, J. (2004). Reduction of quantity smoked predicts future cessation among older smokers. Addiction, 99, 93-102.
6. Hatsukami, D. K., Ebbert, J. O., Anderson, A., Lin, H., Le, C., & Hecht, S. S. (2007). Smokeless tobacco brand switching: A means to reduce toxicant exposure? Drug and Alcohol Dependence, 87, 217-224.
7. Hatsukami, D. K., Ebbert, J. O., Edmonds, A., Li, C., Lin, H., Le, C., et al. (2008). Smokeless tobacco reduction: Preliminary study of tobacco-free snuff versus no snuff. Nicotine & Tobacco Research, 10, 77-85.
8. Henley, S. J., Thun, M. J., Connell, C., & Calle, E. E. (2005). Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes & Control, 16, 347-358.
9. Hughes, J. R., Callas, P. W., & Peters, E. N. (2007). Interest in gradual cessation. Nicotine & Tobacco Research, 9, 671-675.
10. McNeill, A. (2004). Harm reduction. BMJ, 328, 885-887.
11. National Institute of Health. (2006). National Institutes of Health State-of-the-Science Conference Statement: Tobacco use: Prevention, cessation, and control. Annals of Internal Medicine, 145, 839-844.
12. Posner, K. (2007). Suicidality issues in clinical trials: Columbia Suicide Adverse Event Identification in FDA Safety Analyses. Retrieved from http://www.fda.gov/ohrms/dockets/ac/07/slides/2007-4306s1-01-CU-Posner.ppt
13. Posner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007). Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. American Journal of Psychiatry, 164, 1035-1043.
14. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
15. Stead, L. F., & Lancaster, T. (2007). Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews(3), CD005231.
16. Substance Abuse and Mental Health Services Administration. (2009). Results from the 2008 National Survey on Drug Use and Health: National findings. (NSDUH Series H-36, HHS Publication No. SMA 09-4434) Rockville, MD: Office of Applied Studies.
17. Wang, D., Connock, M., Barton, P., Fry-Smith, A., Aveyard, P., & Moore, D. (2008). 'Cut down to quit' with nicotine replacement therapies in smoking cessation: A systematic review of effectiveness and economic analysis. Health Technology Assessment, 12(2), iii-iv. ix-xi, 1-135.